Also found in: Wikipedia.
VAFSVaccine-Associated Feline Sarcoma (feline cancer)
References in periodicals archive ?
Across both challenges, the most commonly missed SNVs were those with low simulated VAFs (10%-15%), accounting for 2 of 4 missed SNVs in the first challenge and 4 of 6 missed SNVs in the second challenge.
Although not all laboratories include VAFs in their clinical reports, we sought to determine the level of reported VAF concordance in this data set.
9,25) Traditional analyte-specific and MBPT paradigms for NGS do not comprehensively evaluate bioinformatics pipelines because of the expense and difficulty involved in creating a full spectrum of mutations and range of VAFs in the PT challenge materials.
That is, half of the participants varied their appropriate social behaviors as a function of their therapists' attention, with VAFs higher than 50 %.
However, this finding needs to be studied further and with a larger sample size, as there were some qualitative changes in social sensitivity and behavioral bias over time; more participants had VAFs higher than 50 % and higher biases after 8 months of intervention.
Paired t tests were used to measure the changes in sensitivity, bias, and VAF between Ti and T2.
Swagelok VAFs are available with NPT and flange end connections in sizes from 1/8 to 1 1/4 in.
We also observed strong concordance between the VAFs obtained through a duplex [15.
6) also found strong correlations between the VAFs inferred independently by duplex and multiplex assays targeting the same mutations and the VAFs inferred through ddPCR and qPCR.
Though inverted ddPCR assay hold promise for the detection of rare mutations in fresh tumor and FFPE biopsies with VAFs around 10% and higher (Fig.
However, according to ABBS, the VAFS technology would permit reducing the "V" angle allowing to lower the floor and thus the centre of gravity, and thereby reduce vehicle profile or conversely increase internal volume, an overall positive trade-off for the presence of the columns containing or supporting rocket engines and redistributing forces on the floor.
CA15-3, ID months Age (a) ER PR HER2 U/mL 1 Baseline 52 pos (b) pos pos 602 5 376 2 Baseline 45 pos pos neg 25 20 131 3 Baseline 74 pos pos neg 29 14 24 4 Baseline 80 pos pos neg 150 2 194 5 Baseline 49 pos pos pos 23 2 23 6 Baseline 27 pos pos neg 23 11 23 17 25 24 56 7 Baseline 72 pos NA neg 314 1 395 8 Baseline 51 pos pos neg 20 7 46 9 221 10 567 13 252 9 Baseline 43 pos pos neg 74 3 110 6 168 12 147 13 138 cfDNA SNV (AA mutation) and VAF Patient genomic ID copies/mL Gene Mutation VAF, % Coverage 1 2076 PIK3CA P.